What are the proper reconstitution instructions for meropenem (carbapenem antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Meropenem Reconstitution Instructions

Reconstitute meropenem vials with Sterile Water for Injection: add 10 mL to 500 mg vials or 20 mL to 1 gram vials, shake to dissolve until clear, yielding a 50 mg/mL concentration 1.

Reconstitution Details

For IV Bolus Administration

  • 500 mg vial: Add 10 mL Sterile Water for Injection
  • 1 gram vial: Add 20 mL Sterile Water for Injection
  • Final concentration: 50 mg/mL for both
  • Shake vigorously and allow to stand until solution is clear
  • Visually inspect for particulate matter and discoloration before use 1

For IV Infusion

You have two options:

  • Direct reconstitution: Reconstitute vials directly with compatible infusion fluid (0.9% Sodium Chloride or 5% Dextrose)
  • Two-step method: First reconstitute with Sterile Water for Injection as above, then add to IV container and further dilute with infusion fluid
  • Target concentration for infusion: 1-20 mg/mL 1

Critical Stability Considerations

Meropenem has limited stability once reconstituted—this is the most important pitfall to avoid. The drug degrades rapidly at room temperature, particularly compared to other carbapenems 2.

Storage Times After Reconstitution

For IV Bolus (50 mg/mL in Sterile Water):

  • Room temperature (up to 25°C): 3 hours maximum
  • Refrigerated (up to 5°C): 13 hours maximum 1

For IV Infusion in 0.9% Sodium Chloride (1-20 mg/mL):

  • Room temperature (up to 25°C): 1 hour maximum
  • Refrigerated (up to 5°C): 15 hours maximum 1

For IV Infusion in 5% Dextrose (1-20 mg/mL):

  • Use immediately—no storage time 1

Temperature-Dependent Degradation

Research confirms the FDA stability data: meropenem stability is highly temperature-dependent. At 22°C, concentrations drop to 90% at 7.4 hours; at 33°C, this occurs at only 5.7 hours 3. In tropical climates without air conditioning (32-37°C), degradation reaches 11.85% after 8 hours 4. Never freeze meropenem solutions 1.

Administration Guidelines

  • Standard infusion: 15-30 minutes
  • Bolus injection: 1 gram doses may be given over 3-5 minutes (5-20 mL volume)
  • Do not mix with other drugs—compatibility has not been established 1

Practical Implications for Continuous Infusion

While continuous infusion optimizes meropenem's time-dependent killing 2, the limited stability creates challenges. Meropenem has stability of only 6-12 hours at 25°C depending on concentration 2. For continuous infusion in critically ill patients, the daily dose must be divided into multiple freshly prepared doses rather than a single 24-hour bag 2. Solutions at 10-20 mg/mL remain stable for 12 hours at 25°C in 0.9% sodium chloride, while 40 mg/mL solutions are stable for only 8 hours 5.

Key Pitfalls to Avoid

  • Never prepare 24-hour continuous infusion bags—meropenem will degrade below therapeutic levels
  • Avoid 5% Dextrose for storage—use immediately or choose 0.9% Sodium Chloride instead
  • Monitor room temperature—higher ambient temperatures dramatically reduce stability
  • Prepare fresh solutions—the FDA emphasizes freshly prepared solutions should be used whenever possible 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.